|Articles|November 21, 2022
Quality Control Analysis of Oligonucleotide Therapeutics: One Platform Method for Determining Identity, Purity, and Quantity
Author(s)Waters
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
3
Norgine Secures Hepatitis Delta Therapy Rights Across Key Region
4
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
5